TARS - Tarsus Pharmaceuticals, Inc.

📈 Is growth accelerating? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2020 10-Q ↗	Q2 FY2020 Sep 30, 2020 10-Q ↗	Q1 FY2020 Jun 30, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Dec 31, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Revenue Growth YoY (%)	106.9% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1236%)	128.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1505%)	146.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1733%)	151.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1794%)	183.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2196%)	407.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4998%)	2471.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+30797%)	—	—	30.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+284%)	—	—	—	2858.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+35632%)	N/M	-30.6% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-483%)	-98.4% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1330%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	75.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	67.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	50.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	45.5% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	36.6% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	53.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	52.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	24.8% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-14.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-159.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-52.4% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-387.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	10.2% Fair → Fair Stable Year-over-year change in earnings per share Optimal: > 10%	31.9% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-10.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	N/M	79.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	72.3% Excellent ↑ Excellent Improving Year-over-year change in net income	63.8% Excellent ↑ Excellent Improving Year-over-year change in net income	29.7% Excellent ↓ Excellent Declining Year-over-year change in net income	29.7% Excellent ↑ Excellent Improving Year-over-year change in net income	29.7% Excellent ↑ Excellent Improving Year-over-year change in net income	44.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-52.6% Weak ↑ Weak Improving Year-over-year change in net income	-52.6% Weak ↑ Weak Improving Year-over-year change in net income	-52.6% Weak ↑ Weak Improving Year-over-year change in net income	-208.1% Weak ↓ Weak Declining Year-over-year change in net income	-15.7% Weak ↓ Weak Declining Year-over-year change in net income	-15.7% Weak ↓ Weak Declining Year-over-year change in net income	-15.7% Weak Weak Year-over-year change in net income	8.4% Fair Fair Year-over-year change in net income	N/M	N/M	N/M	-29.5% Weak Weak Year-over-year change in net income	N/M	N/M	N/M	-712.1% Weak Weak Year-over-year change in net income	-12.1% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—	—
FCF Growth YoY (%)	-31.4% Weak Weak Year-over-year change in free cash flow	—	—	—	49.8% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-28.9% Weak Weak Year-over-year change in free cash flow	—	—	—	-11.9% Weak Weak Year-over-year change in free cash flow	—	—	—	-26.7% Weak Weak Year-over-year change in free cash flow	—	—	—	23.2% Good Good Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	147.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	—	88.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	425.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	481.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	238.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	22.8% Excellent Excellent Compound annual revenue growth over 3 years	-6.2% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	37.1% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2020 10-Q ↗	Q2 FY2020 Sep 30, 2020 10-Q ↗	Q1 FY2020 Jun 30, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Dec 31, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Operating Margin (%) (%)	-3.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-125%)	-5.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-135%)	-12.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-182%)	-21.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-244%)	-33.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-324%)	-36.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-345%)	-52.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-449%)	-81.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-644%)	-136.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1010%)	-339.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2366%)	—	—	—	-150.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1104%)	—	-34.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-328%)	—	—	—	33.1% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+120%)	32.0% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+114%)	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	-4.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-136%)	-5.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-146%)	-21.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-276%)	-24.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-304%)	-32.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-367%)	-34.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-390%)	-74.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-719%)	-87.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-830%)	-129.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1178%)	-320.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2770%)	—	—	—	-136.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1233%)	—	-132.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1204%)	—	—	—	47.1% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+293%)	31.0% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+159%)	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-18.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	8.6% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	13.8% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	-29.6% Weak → Weak Stable Free cash flow as a percentage of revenue Optimal: > 10%	-27.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-33.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-137.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-300.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	-110.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	-35.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	4.37x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-1.55x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.65x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.21x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.06x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.95x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.76x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	-1.15x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	3.43x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.48x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.04x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2020 10-Q ↗	Q2 FY2020 Sep 30, 2020 10-Q ↗	Q1 FY2020 Jun 30, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Dec 31, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Return on Invested Capital (%)	-1.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-1.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-2.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-17.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.2% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-8.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-1.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	3.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	4.6% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	44.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	23.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	21.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	14.3% Good Good Return earned on debt + equity capital invested Optimal: > 10%	10.9% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—
Return on Capital (%) (%)	-1.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-1.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-2.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-15.3% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-17.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-9.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-2.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	3.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	5.5% Caution Caution Operating profit relative to total assets Optimal: > 10%	-6.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-1.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	-2.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-113%)	-2.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-116%)	-7.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-150%)	-7.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-150%)	-7.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-149%)	-10.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-169%)	-15.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-200%)	-14.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-194%)	-13.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-187%)	-21.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-242%)	-11.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-173%)	-15.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-206%)	-13.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-190%)	-7.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-147%)	-10.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-167%)	-9.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-161%)	-13.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-190%)	-8.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-159%)	5.8% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-61%)	5.4% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-64%)	5.7% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-62%)	-6.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-146%)	11.0% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-27%)	17.7% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+18%)	24.6% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+64%)	23.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+57%)	38.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+153%)	—	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2020 10-Q ↗	Q2 FY2020 Sep 30, 2020 10-Q ↗	Q1 FY2020 Jun 30, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Dec 31, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Debt to Equity (x)	0.21x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-65%)	0.21x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-65%)	0.22x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-64%)	0.22x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-64%)	0.21x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-65%)	0.32x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-47%)	0.30x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-50%)	0.28x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-53%)	0.11x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-82%)	—	0.14x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-77%)	0.17x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-72%)	0.14x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-76%)	—	0.10x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-84%)	0.09x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-86%)	0.13x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-79%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	-2.88x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3.60x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6.41x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-9.90x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-11.88x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-10.56x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-10.29x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-15.79x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-38.34x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-44.94x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-47.71x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-40.27x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-36.48x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-21.76x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-36.19x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-9.59x Weak Weak Operating income divided by interest expense Optimal: > 5x	-59.33x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-29.59M	$-111.20M	$-40.44M	$-24.52M	$-103.80M	$-22.97M	$-104.50M	$-109.52M	$-163.77M	—	$-196.96M	$-82.17M	$-41.48M	—	$-150.13M	$-226.10M	$-155.83M	$-171.33M	$-183.80M	$-176.74M	$-156.18M	$-168.13M	$-86.33M	$-53.13M	$-55.89M	$-57.95M	$-337.00K	—	—	—	—
Debt / EBITDA (x)	-12.25x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-9.32x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-5.04x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-3.28x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.76x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.97x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.87x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.16x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.80x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-0.73x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.75x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.99x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-0.85x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-3.75x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.98x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 8 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2020 10-Q ↗	Q2 FY2020 Sep 30, 2020 10-Q ↗	Q1 FY2020 Jun 30, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Dec 31, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Revenue per Share (USD)	$3.77	—	$2.79	$2.42	$1.99	—	$1.25	$1.08	$0.78	—	$0.06	—	—	—	$0.00	$0.63	$0.03	—	$0.06	$1.07	$1.64	—	$0.00	$0.00	$0.00	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.16	$-0.19	$-0.30	$-0.48	$-0.64	$-0.59	$-0.61	$-0.88	$-1.01	$-1.27	$-1.28	$-1.17	$-0.88	$-0.49	$-0.84	$-0.24	$-0.98	$-0.72	$-0.76	$0.31	$0.51	$1.41	$-3.71	$-1.23	$-0.74	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.71	—	$0.38	$-0.72	$-0.54	—	—	—	$-1.08	—	—	—	$-0.83	—	—	—	$-0.75	—	—	—	$-0.59	—	$-2.46	$-1.09	$-0.77	—	—	—	—	—	—
Dividend per Share (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	—	—	—	—	—
Book Value per Share (USD)	$8.11	$8.07	$7.89	$7.88	$8.15	$5.85	$6.22	$6.63	$7.29	—	$6.45	$5.49	$6.47	—	$7.60	$8.31	$7.20	$8.06	$8.67	$9.36	$8.93	$8.17	$-6.53	$-4.16	$-3.00	$-2.27	—	—	—	—	—
Tangible Book Value per Share (USD)	$7.95	$7.90	$7.71	$7.69	$7.96	$5.64	$5.99	$6.54	$7.19	—	$6.33	$5.49	$6.47	—	$7.60	$8.31	$7.20	$8.06	$8.67	$9.36	$8.93	$8.17	$-6.53	$-4.16	$-3.00	$-2.27	—	—	—	—	—
Basic Weighted Avg Shares (shares)	42.96M	—	42.61M	42.36M	39.35M	—	38.38M	37.82M	35.30M	—	30.62M	26.82M	26.74M	—	26.66M	24.33M	20.71M	—	20.64M	20.56M	20.34M	—	2.73M	2.65M	2.65M	—	—	—	—	—	—
Dividend Payout Ratio (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2020 10-Q ↗	Q2 FY2020 Sep 30, 2020 10-Q ↗	Q1 FY2020 Jun 30, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Dec 31, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Working Capital (USD)	$393.72M	$387.09M	$384.65M	$384.18M	$394.46M	$276.09M	$291.25M	$311.02M	$298.20M	—	$236.03M	$168.71M	$195.39M	—	$219.81M	$238.56M	$166.15M	$164.47M	$176.72M	$190.45M	$181.33M	$165.27M	—	—	—	$57.21M	—	—	—	—	—
LT Debt (USD)	$72.60M	$72.44M	$72.28M	$72.13M	$71.98M	$71.84M	$71.71M	$71.58M	$29.93M	—	$29.71M	$24.61M	$24.52M	—	$19.36M	$19.26M	$19.18M	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$348.95M	$343.43M	$335.08M	$332.61M	$342.46M	$224.53M	$237.48M	$252.25M	$275.21M	$196.99M	$213.66M	$147.73M	$173.40M	$192.90M	$202.63M	$221.50M	$149.20M	$166.73M	$179.14M	$192.47M	$183.23M	$165.98M	$-17.83M	$-11.04M	$-7.96M	$-6.00M	$-4.60M	$-3.92M	$-3.10M	$-1.35M	$-44.00K

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Dec 31, 2020 10-Q ↗	Q2 FY2020 Sep 30, 2020 10-Q ↗	Q1 FY2020 Jun 30, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Dec 31, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Sales/Revenue/Turnover (USD)	$162.05M	$151.67M	$118.70M	$102.66M	$78.33M	$66.41M	$48.12M	$40.81M	$27.61M	$13.08M	$1.87M	—	—	$10.00M	$0.00	$15.28M	$539.00K	$338.00K	$1.24M	$22.02M	$33.43M	$0.00	$0.00	$0.00	$0.00	—	—	—	—	—	—
Depreciation Expense (USD)	$197.00K	$202.00K	$200.00K	$200.00K	$220.00K	$192.00K	$200.00K	$100.00K	$170.00K	$247.00K	$200.00K	$200.00K	$100.00K	$99.00K	$100.00K	$92.00K	$41.00K	$0.00	$100.00K	$125.00K	$64.00K	$0.00	$24.00K	$17.00K	$15.00K	$19.00K	$9.00K	—	—	—	—
Net Income, GAAP (USD)	$-6.97M	$-8.37M	$-25.12M	$-25.12M	$-25.12M	$-23.11M	$-35.73M	$-35.73M	$-35.73M	$-41.90M	$-23.42M	$-23.42M	$-23.42M	$-13.60M	$-20.24M	$-20.24M	$-20.24M	$-14.85M	$10.38M	$10.38M	$10.38M	$-11.47M	$-1.96M	$-1.96M	$-1.96M	$-1.41M	$-1.75M	—	—	—	—
Operating Cash Flow (USD)	$-24.65M	$19.33M	$18.26M	$-29.39M	$-20.65M	$-22.18M	—	—	$-37.79M	$-39.34M	—	—	$-21.97M	$-10.87M	—	—	$-15.29M	$-12.12M	—	—	$-11.79M	$-10.01M	$-6.57M	$-2.56M	$-2.00M	$-806.00K	—	—	—	—	—

Tarsus Pharmaceuticals, Inc.

Analytical Summary

31-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare TARS with peers